You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 1, January 12, 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thrombocytosis in Polymyalgia Rheumatica: An Additional Diagnostic Criterion and Possible Risk Factor for Ischemic Complications?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The articles by Brooks and McGee1 and Gonzalez-Gay et al2 describe the diagnostic dilemmas associated with polymyalgia rheumatica (PMR), especially in patients with atypical features and a normal erythrocyte sedimentation rate (ESR). Clinically, patients with PMR often present with initial thrombocytosis, a fact that has not been addressed in the literature. To examine the relevance of early thrombocytosis in PMR, we performed a retrospective study of 23 patients (14 women and 9 men; mean age, 67.3 years) who fulfilled Bird's diagnostic criteria1 for PMR after exclusion of individuals with disorders that have similar clinical manifestations, such as infections, malignant neoplasms, and collagen disorders. A prompt response to corticosteroid therapy was documented in all patients. Seven of the patients had biopsy-proved temporal arteritis, clinical details of which are described elsewhere.3 Platelet counts, ESR, and C-reactive protein (CRP) levels were monitored during diagnostic workup and for the first 3 weeks after initiation . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Polymyalgia Rheumatica Without Significantly Increased Erythrocyte Sedimentation Rate: A More Benign Syndrome
Miguel A. González-Gay, Vicente Rodríiguez-Valverde, Ricardo Blanco, Jose L. Fernández-Sueiro, Jose Armona, Manuel Figueroa, and Victor M. Martínez-Taboada
Arch Intern Med. 1997;157(3):317-320.
ABSTRACT  

Diagnostic Dilemmas in Polymyalgia Rheumatica
Robert C. Brooks and Steven R. McGee
Arch Intern Med. 1997;157(2):162-168.
ABSTRACT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

70/30 Insulin Algorithm Versus Sliding Scale Insulin
Schoeffler et al.
The Annals of Pharmacotherapy 2005;39:1606-1609.
ABSTRACT | FULL TEXT  

Management of Diabetes and Hyperglycemia in Hospitals
Clement et al.
Diabetes Care 2004;27:553-591.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.